The Bull Rankings scorecard — our quality-growth score is 69.3 / 100, built from three pillars scored 0–100: Quality 54, Growth 89, Value 69 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free cash flow shrinking about 2% next year, then recovering toward 3% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
Amcor’s growth engine is humming. In the quarter ended 2026-06-30, revenue surged 56.6% year over year, a figure so outsized it demands a closer look: most of that jump came from the all-stock acquisition of Berry Global, not organic demand. The market, however, is treating this as a one-off spike rather than a repeatable trend, pricing in a reverse-DCF implied free-cash-flow decline of about -2% per year (in year one, recovering toward 3% a year by year ten). Our model’s quality-growth score of 69.3/100—with Growth at 89 and Quality at 54—takes that jump at face value, so the Growth pillar runs ahead of the organic trend. The PEG ratio of 1.05 tells a similar story: the multiple is high, but not absurd, if the growth is real. The stock sits in the middle of its 52-week range, leaving little margin for error. The bull case hinges on whether this revenue burst is the start of a new cycle or a temporary surge that will fade under the weight of its own scale.
What the business actually is
Amcor doesn’t just make boxes. It prints, molds, and laminates packaging for nutrition, health, beauty, and wellness across four continents. The Global Flexible Packaging Solutions segment is the revenue engine, supplying polymer resin, aluminum, and fiber-based flexible packaging—think squeeze tubes for sunscreen, laminated pouches for snacks, and barrier films for pharmaceuticals. The company’s product list reads like a catalog of modern consumer essentials: bottles, vials, jars, lids, trays, and even applicators for beauty products. When Ocean Potion partners with Amcor to create a ripple-effect tube for sunscreen, it’s not a side project; it’s a showcase of the segment’s design and printing capabilities. This is a business built on precision, not scale alone.
Why it can (or can't) keep compounding
The moat is in the details. A 9.4% return on equity in the latest quarter shows capital is working, but the real advantage is in the segment’s ability to lock in customers with proprietary structures. Flexible packaging isn’t a commodity when the printing process, material science, and end-market compliance matter as much as the container itself. Competitors can buy machines, but replicating Amcor’s decades of relationships with global brands in nutrition, health, and beauty takes time. The model’s Growth pillar at 89 reflects the acquisition-driven revenue jump, but the Quality pillar at 54 warns that margins are still thin—4.7% profit margin—and debt levels are elevated, with a debt-to-equity ratio of 1.28. The question isn’t whether Amcor can grow, but whether it can grow profitably while servicing that leverage.
The valuation question
The market is pricing in a bet that Amcor’s growth will stall. A PE of 19.1 isn’t cheap, but it’s not punitive for a growth stock—especially when free cash flow for the trailing twelve months sits at $1.2 billion. The reverse-DCF, though, is the killer. A -2% annual free-cash-flow decline (in year one, recovering toward 3% a year by year ten) baked into today’s price assumes the revenue surge is a mirage. That looks gloomy for a company that just posted 56.6% growth, even allowing for the acquisition. The analyst consensus splits the difference, with a 12-analyst mean target of $50.18 and a range from $42 to $60. The stock’s 52-week range—$36.25 to $50.94—tells the same story: the market is undecided, and the price is stuck in the middle.
The bear case
The weakest pillar in our model is Quality, and the numbers back it up. A debt-to-equity ratio of 1.28 isn’t a death knell, but it limits financial flexibility in a rising-rate world. The 4.7% profit margin is thin for a company of this scale, and if growth slows even modestly, that margin could compress further. The bear case argues that Amcor’s recent revenue spike came from buying Berry Global, not from organic demand. If that’s true, the reverse-DCF implied -2% free-cash-flow decline starts to look realistic rather than pessimistic.
What would change our mind
Three things would flip the thesis. First, if the debt-to-equity ratio drops below 1.0 in the next quarterly report, the Quality pillar would strengthen enough to justify the current multiple. Second, if the profit margin climbs above 5.5%, it would signal that the growth is translating into real earnings power, not just top-line bloat. Finally, if the revenue growth rate stabilizes above 8% annually—not the 56.6% surge, but a sustainable clip—the reverse-DCF implied -2% free-cash-flow decline would look like a mispricing, not a fair bet. Until then, the stock is a growth story priced for disappointment.